Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NM-002 in Adult Patients With Short Bowel Syndrome
NCT04379856Phase 2Unknown
- Sponsor
- Innovate Biopharmaceuticals
- Start
- Jun 2020
- Primary completion
- Dec 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of vurolenatide in short bowel syndrome (SBS), sponsored by Innovate Biopharmaceuticals. Status: unknown.
02
Drugs
vurolenatide
03
Conditions
short bowel syndrome (SBS)
Beyond the preview
Go deeper on NCT04379856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04379856.